Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression.

Context.-- Human epidermal growth factor receptor 2 (HER2) status in breast cancer is currently classified as negative or positive for selecting patients for anti-HER2 targeted therapy. The evolution of the HER2 status has included a new HER2-low category defined as an HER2 immunohistochemistry scor...

Full description

Bibliographic Details

Published in:	Archives of Pathology & Laboratory Medicine Vol. 148; no. 2; pp. 242 - 256
Main Authors:	Tozbikian, Gary, Krishnamurthy, Savitri, Bui, Marilyn M., Feldman, Michael, Hicks, David G., Jaffer, Shabnam, Khoury, Thaer, Shi Wei, Wen, Hannah, Pohlmann, Paula
Format:	pictorial review tables/charts Journal Article
Published:	College of American Pathologists Feb2024
Online Access:	View this record in EBSCOhost